RDHL

RedHill Biopharma Ltd. (RDHL) is a biopharmaceutical firm based in Tel Aviv, dedicated to the development and commercialization of innovative therapies for gastrointestinal and infectious diseases. The company is characterized by a robust and diversified pipeline, underpinned by proprietary products and strategic partnerships that target significant unmet medical needs. Leveraging its strong capabilities in clinical research and regulatory affairs, RedHill is committed to improving patient outcomes while expanding its footprint in both niche and broader healthcare markets, thereby establishing itself as a vital participant in the biopharmaceutical sector.